Search - Université Paris Cité Access content directly

Filter your results

54 Results
authFullName_s : Yannick Allanore
Image document

Targeting Costimulatory Pathways in Systemic Sclerosis

Gonçalo Boleto , Yannick Allanore , Jérôme Avouac
Frontiers in Immunology, 2018, 9, ⟨10.3389/fimmu.2018.02998⟩
Journal articles hal-02134109v1
Image document

Correlations between angiogenic factors and capillaroscopic patterns in systemic sclerosis.

Jérôme Avouac , Maeva Vallucci , Vanessa Smith , Patricia Senet , Barbara Ruiz et al.
Arthritis Research and Therapy, 2013, 15 (2), pp.R55. ⟨10.1186/ar4217⟩
Journal articles inserm-00827903v1
Image document

Nifedipine protects against overproduction of superoxide anion by monocytes from patients with systemic sclerosis.

Yannick Allanore , Didier Borderie , Axel Périanin , Hervé Lemaréchal , Ohvanesse Garabed Ekindjian et al.
Arthritis Research and Therapy, 2005, 7, pp.R93-100. ⟨10.1186/ar1457⟩
Journal articles inserm-00096184v1

The role of antifibrotic therapies in the treatment of systemic sclerosis–associated interstitial lung disease

Gonçalo Boleto , Jérôme Avouac , Yannick Allanore
Therapeutic advances in musculoskeletal disease, 2022, 14, pp.1759720X2110666. ⟨10.1177/1759720X211066686⟩
Journal articles hal-03985039v1

C8orf13-BLK Is a Genetic Risk Locus for Systemic Sclerosis and Has Additive Effects With BANK1: Results From a Large French Cohort and Meta-Analysis

Baptiste Coustet , Philippe Dieudé , Mickael Guedj , Mathieu Bouaziz , Jerome Avouac et al.
Arthritis and Rheumatism, 2011, 63 (7), pp.2091 - 2096. ⟨10.1002/art.30379⟩
Journal articles hal-02650698v1

Association Study of ITGAM, ITGAX, and CD58 Autoimmune Risk Loci in Systemic Sclerosis: Results from 2 Large European Caucasian Cohorts

Baptiste Coustet , Sandeep K. Agarwal , Pravitt Gourh , Mickael Guedj , Maureen D. Mayes et al.
Journal of Rheumatology, 2011, 38 (6), pp.1033 - 1038. ⟨10.3899/jrheum.101053⟩
Journal articles hal-02646961v1

A candidate gene study identifies a haplotype of CD2 as novel susceptibility factor for systemic sclerosis

Eugenie Koumakis , Maissa Bouaziz , Phillipe Dieudé , Anne Cauvet , B. Ruiz et al.
Clinical and experimental rheumatology, 2016, 34 (5), pp.S43-S48
Journal articles hal-01606686v1

Semaphorins: From Angiogenesis to Inflammation in Rheumatoid Arthritis

Jérôme Avouac , Sonia Pezet , Eloïse Vandebeuque , Cindy Orvain , Virginie Gonzalez et al.
Arthritis & rheumatology, 2021, 73 (9), pp.1579-1588. ⟨10.1002/art.41701⟩
Journal articles hal-03660130v1

Implication of the deacetylase sirtuin-1 on synovial angiogenesis and persistence of experimental arthritis

Agathe Leblond , Sonia Pezet , Anne Cauvet , Claudine Casas , Julie Pires da Silva et al.
Annals of the Rheumatic Diseases, 2020, 79 (7), pp.891-900. ⟨10.1136/annrheumdis-2020-217377⟩
Journal articles hal-02927538v1
Image document

T-cell costimulation blockade is effective in experimental digestive and lung tissue fibrosis

Gonçalo Boleto , Christophe Guignabert , Sonia Pezet , Anne Cauvet , Jérémy Sadoine et al.
Arthritis Research & Therapy, 2018, 20 (1), pp.197. ⟨10.1186/s13075-018-1694-9⟩
Journal articles hal-03828440v1

Raynaud phenomenon and digital ulcers in systemic sclerosis

Michael Hughes , Yannick Allanore , Lorinda Chung , John Pauling , Christopher Denton et al.
Nature Reviews Rheumatology, 2020, 16 (4), pp.208-221. ⟨10.1038/s41584-020-0386-4⟩
Journal articles hal-03984961v1

Semaphorins: From Angiogenesis to Inflammation in Rheumatoid Arthritis

Jérôme Avouac , Sonia Pezet , Eloïse Vandebeuque , Cindy Orvain , Virginie Gonzalez et al.
Arthritis & rheumatology, 2021, 73 (9), pp.1579-1588. ⟨10.1002/art.41701⟩
Journal articles hal-03704363v1

Regulatory T Cells in Systemic Sclerosis

Camelia Frantz , Cedric Auffray , Jerome Avouac , Yannick Allanore
Frontiers in Immunology, 2018, 9, ⟨10.3389/fimmu.2018.02356⟩
Journal articles hal-03894479v1

Risk stratification using anti-citrullinated peptide antibodies (ACPA) in polyarticular subtypes of juvenile idiopathic arthritis in adulthood

Alice Combier , Camelia Frantz , Julien Wipff , Romain Bazeli , Muriel Elhai et al.
Joint Bone Spine, 2023, 90 (2), pp.105501. ⟨10.1016/j.jbspin.2022.105501⟩
Journal articles hal-03934344v1
Image document

Linking systemic angiogenic markers to synovial vascularization in rheumatoid arthritis

Agathe Leblond , Sonia Pezet , Anne Priscille Trouvin , Muriel Elhai , Virginie Gonzalez et al.
PLoS ONE, 2018, 13 (9), pp.e0203607. ⟨10.1371/journal.pone.0203607⟩
Journal articles hal-03828609v1
Image document

Identification of an in vivo orally active dual-binding protein-protein interaction inhibitor targeting TNFα through combined in silico/in vitro/in vivo screening

Lucille Desallais , Jérôme Avouac , Maxime Fréchet , Muriel Elhai , Rojo Ratsimandresy et al.
Scientific Reports, 2017, 7 (1), pp.3424. ⟨10.1038/s41598-017-03427-z⟩
Journal articles inserm-01072217v1
Image document

Comparative efficacy of subcutaneous (CT-P13) and intravenous infliximab in adult patients with rheumatoid arthritis: a network meta-regression of individual patient data from two randomised trials

Bernard Combe , Yannick Allanore , Rieke Alten , Roberto Caporali , Patrick Durez et al.
Arthritis Research & Therapy, 2021, 23 (1), pp.119. ⟨10.1186/s13075-021-02487-x⟩
Journal articles hal-03240383v1
Image document

Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective french research axed on tolerance of biotherapies registry.

Florence Tubach , Dominique Salmon , Philippe Ravaud , Yannick Allanore , Philippe Goupille et al.
Arthritis and Rheumatism, 2009, 60 (7), pp.1884-1894. ⟨10.1002/art.24632⟩
Journal articles inserm-00400633v1
Image document

Improving risk-stratification of rheumatoid arthritis patients for interstitial lung disease

Jérôme Avouac , Anne Cauvet , Alexia Steelandt , Yuichiro Shirai , Muriel Elhai et al.
PLoS ONE, 2020, 15 (5), pp.e0232978. ⟨10.1371/journal.pone.0232978⟩
Journal articles inserm-02893338v1
Image document

Targeting CD226/DNAX accessory molecule-1 (DNAM-1) in collagen-induced arthritis mouse models

Muriel Elhai , Gilles Chiocchia , Carmen Marchiol , Franck Lager , Gilles Renault et al.
Journal of Inflammation, 2015, pp.9. ⟨10.1186/s12950-015-0056-5⟩
Journal articles inserm-01159673v1

A regulatory variant in CCR6 is associated with susceptibility to antitopoisomerase-positive systemic sclerosis

Eugenie Koumakis , Matthieu Bouaziz , Philippe Dieudé , Barbara Ruiz , Gabriella Riemekasten et al.
Arthritis and Rheumatism, 2013, 65 (12), pp.3202-3208. ⟨10.1002/art.38136⟩
Journal articles hal-02645040v1
Image document

Role of stromelysin 2 (matrix metalloproteinase 10) as a novel mediator of vascular remodeling underlying pulmonary hypertension associated with systemic sclerosis

Jérôme Avouac , Christophe Guignabert , Anna Maria Hoffmann-Vold , Barbara Ruiz , Peter Dorfmuller et al.
Arthritis & rheumatology, 2017, 69 (11), pp.2209 - 2221. ⟨10.1002/art.40229⟩
Journal articles hal-03828535v1

Clinical characteristics and survival in systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease

David Launay , Marc Humbert , Alice Berezne , Vincent Cottin , Yannick Allanore et al.
Chest, 2011, 140 (4), pp.1016-1024. ⟨10.1378/chest.10-2473⟩
Journal articles hal-02650265v1
Image document

Effects of successive switches to different biosimilars infliximab on immunogenicity in chronic inflammatory diseases in daily clinical practice

Ambre Lauret , Anna Moltó , Vered Abitbol , Loriane Gutermann , Ornella Conort et al.
Seminars in Arthritis and Rheumatism, 2020, 50, pp.1449 - 1456. ⟨10.1016/j.semarthrit.2020.02.007⟩
Journal articles hal-03493478v1
Image document

Identification of NF-κB and PLCL2 as new susceptibility genes and highlights on a potential role of IRF8 through interferon signature modulation in systemic sclerosis

Maria Arismendi , Matthieu Giraud , Nadira Ruzehaji , Philippe Dieudé , Eugenie Koumakis et al.
Arthritis Research and Therapy, 2015, 17 (1), pp.71. ⟨10.1186/s13075-015-0572-y⟩
Journal articles inserm-01160355v1

Acazicolcept (ALPN-101), a dual ICOS/CD28 antagonist, demonstrates efficacy in systemic sclerosis preclinical mouse models

Cindy Orvain , Anne Cauvet , Alexis Prudent , Christophe Guignabert , Raphaël Thuillet et al.
Arthritis Research & Therapy, 2022, 24 (1), pp.13. ⟨10.1186/s13075-021-02709-2⟩
Journal articles hal-03985048v1
Image document

Pan PPAR agonist IVA337 is effective in prevention and treatment of experimental skin fibrosis

Nadira Ruzehaji , Camelia Frantz , Matthieu Ponsoye , Jerome Avouac , Sonia Pezet et al.
Annals of the Rheumatic Diseases, 2016, 75 (12), pp.2175-2183. ⟨10.1136/annrheumdis-2015-208029⟩
Journal articles hal-03828476v1

Natural variability in the disease course of SSc-ILD: implications for treatment

Madelon Vonk , Ulrich Walker , Elizabeth Volkmann , Michael Kreuter , Sindhu Johnson et al.
European Respiratory Review, 2021, 30 (159), pp.200340. ⟨10.1183/16000617.0340-2020⟩
Journal articles hal-03258403v1

Independent Replication and Metaanalysis of Association Studies Establish TNFSF4 as a Susceptibility Gene Preferentially Associated with the Subset of Anticentromere-positive Patients with Systemic Sclerosis

Baptiste Coustet , Matthieu Bouaziz , Philippe Dieudé , Mickael Guedj , Lara Bossini-Castillo et al.
Journal of Rheumatology, 2012, 39 (5), pp.997 - 1003. ⟨10.3899/jrheum.111270⟩
Journal articles hal-02652557v1

Reply to the comment of Brinster et al. “Acquired hemophilia, rheumatoid arthritis, and TNFα antagonists”

Steven Gazal , Karim Sacré , Yannick Allanore , Maria Teruel , Alison H. Goodall et al.
Joint Bone Spine, 2015, 82 (5), pp.385-386. ⟨10.1016/j.jbspin.2015.05.003⟩
Journal articles hal-02467755v1